Programmed cell death and natural killer cells in multiple sclerosis: new potential therapeutic targets?

被引：3
|
作者：
Beatrice Macchi
Antonio Mastino
机构：
[1] Department of Systems Medicine, University of Rome "Tor Vergata"
[2] Department of Chemical, Biological, Pharmaceutical, and Environmental Sciences, University of Messina
[3] The Institute of Translational Pharmacology,CNR
来源：
NeuralRegenerationResearch | 2016年 / 11卷 / 05期
关键词：
new potential therapeutic targets; cell; MS;
D O I：
暂无
中图分类号：
R744.51 [];
学科分类号：
1002 ;
摘要：
Multiple sclerosis(MS)is a chronic,severe and complex disease of still uncertain etiopathogenesis,with lesions in the cerebral white matter and spinal cord.The disease is heterogeneous,but is characterized by neuroinflammatory and neurodegenerative processes,usually associated with altered activation of the immune system following presumable stimulation by still unknown autoantigens.Several data confirm that
引用
收藏
页码：733 / 734
页数：2
相关论文
共 50 条
  • [1] Programmed cell death and natural killer cells in multiple sclerosis: new potential therapeutic targets?
    Macchi, Beatrice
    Mastino, Antonio
    NEURAL REGENERATION RESEARCH, 2016, 11 (05) : 733 - 734
  • [2] The role of natural killer cells in multiple sclerosis and their therapeutic implications
    Chanvillard, Coralie
    Jacolik, Raymond F.
    Infante-Duarte, Carmen
    Nayak, Ramesh C.
    FRONTIERS IN IMMUNOLOGY, 2013, 4
  • [3] Programmed cell death protein 1 on natural killer cells: fact or fiction?
    Cho, Monica M.
    Quamine, Aicha E.
    Olsen, Mallery R.
    Capitini, Christian M.
    JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (06): : 2816 - 2819
  • [4] Caspase-mediated programmed cell death pathways as potential therapeutic targets in cancer
    Wen, X.
    Lin, Z. -Q.
    Liu, B.
    Wei, Y. -Q.
    CELL PROLIFERATION, 2012, 45 (03) : 217 - 224
  • [5] Programmed Cell Death 1 and Programmed Cell Death Ligands in Extranodal Natural Killer/T Cell Lymphoma: Expression Pattern and Potential Prognostic Relevance
    Muhamad, Hamidah
    Suksawai, Narittee
    Assanasen, Thamatorn
    Polprasert, Chantana
    Bunworasate, Udomsak
    Wudhikarn, Kitsada
    ACTA HAEMATOLOGICA, 2020, 143 (01) : 78 - 88
  • [6] Natural killer cells and the immunopathogenesis of multiple sclerosis
    Kastrukoff, LF
    Lau, A
    Zecchinni, D
    ANNALS OF NEUROLOGY, 2000, 48 (03) : 450 - 450
  • [7] Natural killer cells in multiple sclerosis: A review
    Mimpen, Max
    Smolders, Joost
    Hupperts, Raymond
    Damoiseaux, Jan
    IMMUNOLOGY LETTERS, 2020, 222 : 1 - 11
  • [8] Natural killer cells and their receptors in multiple sclerosis
    Kaur, Gurman
    Trowsdale, John
    Fugger, Lars
    BRAIN, 2013, 136 : 2657 - 2676
  • [9] Programmed cell death in nasopharyngeal carcinoma: Mechanisms and therapeutic targets
    Qian, Shen'er
    Tan, Guolin
    Lei, Guang
    Zhang, Xiaowei
    Xie, Zuozhong
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2025, 1880 (01):
  • [10] The meninges: new therapeutic targets for multiple sclerosis
    Russi, Abigail E.
    Brown, Melissa A.
    TRANSLATIONAL RESEARCH, 2015, 165 (02) : 255 - 269
12345